Brief: Immuneering Reports Third Quarter 2021 Financial Results
Nov 9 (Reuters) - Immuneering Corp IMRX.O :
* IMMUNEERING REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
AND
RECENT BUSINESS HIGHLIGHTS
* Q3 LOSS PER SHARE $0.47
* EXPECTS TO FILE IND FOR IMM-1-104 IN Q1 2022
Source text for Eikon: ID:nGNXc73Ffc
Further company coverage: IMRX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Immuneering
See all newsImmuneering expects cash runway to fund operations into 2029
Immuneering posts smaller-than-expected Q1 net loss on lower R&D spend
U.S. STOCKS ON THE MOVE-GoPro, Prudential Financial, Whitestone REIT
U.S. STOCKS ON THE MOVE-US airlines, BlackRock, copper miners
U.S. STOCKS ON THE MOVE-Gap, Caterpillar, Solid Biosciences